MIT’s Koch Institute in strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals
Organizations will collaborate in multiple areas of oncology research and technology development.
Researchers seek to put the squeeze on cancer
Cell contractions may be key to initiating new blood-vessel growth near tumors.
Explained: Directed evolution
Speeding up protein evolution in the lab can yield useful molecules that nature never intended.
Tackling cancer on a new front
New program at MIT’s Koch Institute targets the growing cancer problem in India.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Weighing the cell
MIT biological engineers devise a way to measure, for the first time, how single cells accumulate mass.
To starve a tumor
MIT’s Matthew Vander Heiden is part of a new generation of cancer researchers trying to exploit cancer cells’ strange metabolism.
Listening in on single cells
A novel sensor array is the first to detect single molecules produced by living cells.
New and improved RNA interference
Researchers use RNA interference to silence multiple genes at once. The advance, which one expert calls a ‘substantial breakthrough,’ could lead to new treatments for liver diseases.
Explained: RNA interference
Exploiting the recently discovered mechanism could allow biologists to develop disease treatments by shutting down specific genes.
Nanoparticles for gene therapy improve
MIT team’s nanoparticles could become a safer alternative to gene therapy delivered by viruses.
Possible origins of pancreatic cancer revealed
Tumors can arise from different cell types in the pancreas, depending on the circumstances, according to MIT cancer biologists.
Cancer research gets physical
5-year grant from the National Cancer Institute will fund projects by physicists that give a new view of cancer cells.
Protein is linked to lung cancer development
Drugs that inhibit the protein, which normally helps defend cells from infection, could target tumors in certain lung cancer patients.